1xbet 리뷰., Ltd.

1xbet 리뷰., Ltd. announces that regulatory approval was received on January 19 for the manufacture and sale of Rexulti Tablets^®(generic name is brexpiprazole) in 1mg and 2 mg dosage sizes.

Brexpiprazole is a serotonin-dopamine activity modulator (SDAM) that acts as a partial agonist at 5-HT_1Aand dopamine D₂receptors, and an antagonist at 5-HT_2Aand noradrenaline alpha_1B/2Creceptors.